1. Perceptions of general practitioners on initiation and intensification of type 2 diabetes injectable therapies. A quantitative study in the United Kingdom 
Daniel Sterzi, Sébastien Auziere, Divina Glah, Marie Markert Jensen 
Primary Care Diabetes 
Volume 11, Issue 3, Pages (June 2017)
DOI: /j.pcd
Copyright © 2017 The Authors Terms and Conditions

2. Fig. 1
HbA1c levels at which treatment intensification is needed for each patient group.
Primary Care Diabetes  , DOI: ( /j.pcd )
Copyright © 2017 The Authors Terms and Conditions

3. Fig. 2
Attributes that would increase GPs’ comfort level with initiating injectables. Only top 2 box results are displayed: % of respondents who selected score 6 or 7 on a scale from 1 to 7 where 1=would not impact at all on increasing my comfort level and 7=would impact a lot on increasing my comfort level. The attributes were ranked according to the Top 2 box results for the 1st injectable.
Primary Care Diabetes  , DOI: ( /j.pcd )
Copyright © 2017 The Authors Terms and Conditions

4. Fig. 3
Drivers for the referral to secondary care for initiation of an injectable. The attributes were ranked according to their relative ability to influence treatment referrals, based on the drivers of referral for the 1st injectable. Results are expressed in “winning” percentages (Cohen, 2003) [4]: the modelled percentage of time an attribute is chosen as the “most important/influential” vs. other attributes based on the experimental design. These attributes derived from a qualitative phase undertaken prior to the quantitative study.
Primary Care Diabetes  , DOI: ( /j.pcd )
Copyright © 2017 The Authors Terms and Conditions